Skip to main navigation Skip to search Skip to main content

EYP-1901-301 Wet AMD: A Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects with Wet AMD

Project: Research

Project Details

StatusActive
Effective start/end date04/23/24 → 07/1/27

Funding

  • Syneos Health LLC: $6,604.00